A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.

Autor: Dicanio M; Department of Biology, University of Pisa, Pisa, Italy., Giaccherini M; Department of Biology, University of Pisa, Pisa, Italy., Clay-Gilmour A; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, South Carolina, USA., Macauda A; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sainz J; Genomic Oncology Area, GENYO. Center for Genomics and Oncological Research: Pfizer, University of Granada/Andalusian Regional Government, Granada, Spain.; Department of Hematology, Virgen de las Nieves University Hospital, Granada, Spain.; Department of Medicine, University of Granada, Granada, Spain., Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, Maryland, USA., Rybicka-Ramos M; Department of Hematology Specialist Hospital No. 1, Bytom, Poland., Norman AD; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA.; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA., Tyczyńska A; Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, Maryland, USA., Barington T; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Ontario, USA., Bhatti P; Cancer Control Research, BC Cancer, Vancouver, Canada.; Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Cozen W; Division of Hematology/Oncology, Department of Medicine, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California, Irvine, California, USA.; Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California, Irvine, California, USA., Brown EE; Department of Pathology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Suska A; Plasma Cell Dyscrasia Center Department of Hematology Jagiellonian University Faculty of Medicine, Kraków, Poland., Haastrup EK; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Orlowski RZ; Department of Lymphoma - Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dudziński M; Department of Hematology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland., Garcia-Sanz R; Medina A. Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain., Kruszewski M; Department of Hematology, University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland., Martinez-Lopez J; Hospital 12 de Octubre, Compluntense University, CNIO, CIBERONC, Madrid, Spain., Beider K; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel., Iskierka-Jazdzewska E; Department of Hematology, Medical University of Lodz, Łódź, Poland., Pelosini M; U.O. Dipartimento di Ematologia, Azienda USL Toscana Nord Ovest, Livorno, Italy., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, Maryland, USA., Raźny M; Department of Hematology, Rydygier Hospital, Cracow, Poland., Jamroziak K; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Ontario, USA., Jurczyszyn A; Plasma Cell Dyscrasia Center Department of Hematology Jagiellonian University Faculty of Medicine, Kraków, Poland., Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Collado PG; Department of Hematology, Virgen de las Nieves University Hospital, Granada, Spain., Vogel U; National Research Center for the Working Environment, Copenhagen, Denmark., Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institues of Health, Bethesda, Maryland, USA., Petrini M; Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Butrym A; Department of Cancer Prevention and Therapy, Wroclaw Medical University, Wroclaw, Poland., Slager SL; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA., Ziv E; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., Subocz E; Department of Hematology, Military Institute of Medicine, Warsaw, Poland., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Center for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Andersen NF; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Mazur G; Department of Internal Diseases, Occupational Medicine, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland., Watek M; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Department of Hematology, Holycross Cancer Center, Kielce, Poland., Lesueur F; Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, Paris, France., Hildebrandt MAT; Department of Lymphoma - Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zawirska D; Department of Hematology, University Hospital in Cracow, Cracow, Poland., Ebbesen LH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Marques H; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal and ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Gemignani F; Department of Biology, University of Pisa, Pisa, Italy., Dumontet C; INSERM 1052/CNRS 5286/University of Lyon, Lyon, France., Várkonyi J; Department of Hematology and Internal Medicine, Semmelweis University, Budapest, Hungary., Buda G; Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Nagler A; Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel., Druzd-Sitek A; Department of Lymphoproliferative Diseases, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Wu X; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadar K; Department of Hematology and Internal Medicine, Semmelweis University, Budapest, Hungary., Camp NJ; Division of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Grzasko N; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland., Waller RG; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA., Vachon C; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Ontario, USA., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Campa D; Department of Biology, University of Pisa, Pisa, Italy.

Publikováno v: International journal of cancer [Int J Cancer] 2023 Jan 15; Vol. 152 (2), pp. 239-248. Date of Electronic Publication: 2022 Oct 01.